NIH AI Restriction
NIH policy NOT-OD-25-132 prohibits the use of AI-generated text in grant applications that is not substantially modified by the applicant. All AI-drafted sections must be thoroughly rewritten in your own words before submission.
View full policyAncillary Studies to Ongoing Clinical Projects (RP1 Clinical Trial Not Allowed)
About This Grant
<p>This Notice of Funding Opportunity (NOFO) solicits applications that propose to conduct time-sensitive ancillary studies in conjunction with privately or publicly funded, active, ongoing clinical projects (parent projects). The parent project can be an interventional clinical trial, or a clinical study such as an observational study, or a disease-specific repository that will be actively collecting patient samples or clinical data. The parent project(s) should provide a cohort of well-characterized patients, infrastructure, data, and biological samples for the ancillary study. The objective of this NOFO is to provide a flexible mechanism to leverage currently funded resources and maximize the return on existing investments in parent projects. Successful ancillary studies will enhance the scientific content and value of the parent projects, improve the research community’s understanding of a disease or organ system and thus may identify novel targets for diagnosis, treatment, and prevention of disease.</p>
Grant Summary
Ancillary Studies to Ongoing Clinical Projects (RP1 Clinical Trial Not Allowed) is a National Institutes of Health grant providing funding that varies by award for tribal government, school district, university. Applications are due 2026-10-15 (open). Check eligibility and apply with FindGrants.
Not quite the right fit?
Search 9,000+ open grants, or get matches ranked for your organization — free.
Focus Areas
Eligibility
- Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
How to Apply
Up to $0K
2026-10-15
- 1Confirm your organization is eligible for Ancillary Studies to Ongoing Clinical Projects (RP1 Clinical Trial Not Allowed) from National Institutes of Health, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to National Institutes of Health before the deadline.
Search & build free — $99 one-time to unlock the export-ready application pack. No subscription.
Don't want to draft it yourself?
We'll draft the complete application against National Institutes of Health's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Ancillary Studies to Ongoing Clinical Projects (RP1 Clinical Trial Not Allowed): Frequently Asked Questions
Who is eligible for the Ancillary Studies to Ongoing Clinical Projects (RP1 Clinical Trial Not Allowed)?
Ancillary Studies to Ongoing Clinical Projects (RP1 Clinical Trial Not Allowed) is offered by National Institutes of Health and is generally open to tribal government, school district, university, municipality, small business, nonprofit. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Ancillary Studies to Ongoing Clinical Projects (RP1 Clinical Trial Not Allowed) provide?
Ancillary Studies to Ongoing Clinical Projects (RP1 Clinical Trial Not Allowed) provides an amount that varies by award per award from National Institutes of Health. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Ancillary Studies to Ongoing Clinical Projects (RP1 Clinical Trial Not Allowed) deadline?
Applications for Ancillary Studies to Ongoing Clinical Projects (RP1 Clinical Trial Not Allowed) are due 2026-10-15 (open). Because deadlines can change, verify the date with the funder, National Institutes of Health, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the Ancillary Studies to Ongoing Clinical Projects (RP1 Clinical Trial Not Allowed)?
To apply for Ancillary Studies to Ongoing Clinical Projects (RP1 Clinical Trial Not Allowed), confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from National Institutes of Health.